New PD-1 Inhibitor Approved for Esophageal Cancer

(MedPage Today) -- The FDA approved tislelizumab (Tevimbra) for advanced/metastatic esophageal squamous cell carcinoma (ESCC) previously treated with chemotherapy, BeiGene announced.
The approval stipulates use of the PD-1 inhibitor in adults...

Source: MedPage Today Public Health - March 15, 2024 Category: American Health Source Type: news